Skip to main content
. 2020 Jun 25;12(6):592. doi: 10.3390/pharmaceutics12060592

Figure 4.

Figure 4

Self-assembled nanoparticles (SCNs) for the co-delivery of sorafenib and curcumin enhance their therapeutic effect in hepatocellular carcinoma: (A) schematic representation of SCNs, (B) tumor tissues from each group, (C) tumor growth profile [81]. Reprinted with permission from ref. [81], copyright (2015) American Chemical Society.